Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

220.75
+9.644.56%
Post-market: 220.750.00000.00%19:52 EDT
Volume:1.23M
Turnover:273.29M
Market Cap:11.56B
PE:-58.58
High:229.62
Open:212.71
Low:212.44
Close:211.12
52wk High:260.19
52wk Low:112.90
Shares:52.38M
Float Shares:43.83M
Volume Ratio:2.63
T/O Rate:2.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7685
EPS(LYR):-3.6821
ROE:-245.10%
ROA:-16.31%
PB:138.81
PE(LYR):-59.95

Loading ...

Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand

Reuters
·
Aug 11

RBC Adjusts PT on Axsome Therapeutics to $297 From $304, Maintains Outperform Rating

MT Newswires Live
·
Aug 11

U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics

Reuters
·
Aug 11

Faster Revenue Growth With Wider Losses Might Change The Case For Investing In Axsome (AXSM)

Simply Wall St.
·
Aug 11

Movement Alert|Axsome Therapeutics Rises 5.01% in Regular Trading, Q2 Revenue Up 46% YoY as Stock Recovers Pre-Market Losses

Market Focus
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Aug 11

Axsome Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Sector Update: Healthcare Stocks Edge Higher Premarket Monday

MT Newswires Live
·
Aug 10

Axsome Therapeutics Shares Reverse Course Premarket; Last up 2.2%

THOMSON REUTERS
·
Aug 10

Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook

Reuters
·
Aug 10

CervoMed Q2 Net Loss Lower than Estimates as Costs Drop

Reuters
·
Aug 10

Axsome Therapeutics reports Q2 EPS (99c), consensus (85c)

TIPRANKS
·
Aug 10

Axsome Therapeutics Q2 Loss Widens, Revenue Increases

MT Newswires Live
·
Aug 10

Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth

Reuters
·
Aug 10

Axsome Therapeutics Shares Down 8.4% Premarket After Q2 Revenue Miss

THOMSON REUTERS
·
Aug 10

Axsome Q2 FY26 Net Loss Widens to $51.3 Million; Net Product Revenue Climbs 46% to $218.4 Million Year over Year

Reuters
·
Aug 10

Stock Track | Axsome Therapeutics Plunges 5.99% in Pre-market After Q2 Earnings Miss Estimates

Stock Track
·
Aug 10

Earnings Flash (AXSM) Axsome Therapeutics Posts Q2 Loss $0.99 a Share, vs. FactSet Est of $0.89 Loss

MT Newswires Live
·
Aug 10

Axsome Therapeutics Q2 EPS $(0.99) Misses $(0.83) Estimate, Sales $218.400M Miss $221.230M Estimate

Benzinga Earnings
·
Aug 10

Axsome Therapeutics Q2 Net Income USD -51.314 Million

Reuters
·
Aug 10